Effect of synthetic human pancreatic growth hormone-releasing factors on plasma growth hormone concentrations in lactating cows

Two fragments of human pancreatic growth hormone-releasing factor, hpGRF-(1-24)-NH2 and hpGRF(1-29)-NH2, were administered to lactating dairy cows in separate experiments. Each experiment involved a 4 X 4 Latin square with treatments being intravenous administration of saline (controls) or three doses of releasing factor (500, 1000, and 2000 micrograms). Administration of the 24-amino acid fragment increased plasma growth hormone concentration from baseline 3 ng/ml to peak 14 ng/ml within 10 min. Growth hormone concentrations returned to baseline by 60 min post treatment. The 29-amino acid fragment resulted in greater responses in both peak concentration (30 ng/ml) and persistency (greater than 240 min). Relationships between dose of releasing factor and response in growth hormone release (as measured by area under the response curve) were not consistent in most cows. Responses of concentrations of growth hormone in blood plasma that result from intravenous injection of up to 2000 micrograms of growth hormone-releasing factor (1-29) would not be sufficient to increase milk yield of cows.     

Adrenal responsiveness in pre- and postpartum dairy cows.

Adrenal responsiveness was evaluated by injecting 10 multiparous dairy cows with 200 IU adrenocorticotropin between -13 and -2 days prepartum (I) and postpartum between 24 and 40 h (II) and 21 and 24 days (III). Concentrations of glucocorticoids following injection were influenced by day of injection, temperature, and minimum percent relative humidity but not by breed, breed X injection day interaction, or age of cow. Likewise differences in regressions for adrenal response and mean response (ng/ml) for the three injections were nil. Mean concentrations at peak (45, 60, and 120 min postinjection samples) adjusted for preinjection concentrations also did not differ for the three periods of injection. Mean concentrations of glucocorticoids in plasma for daily samples between -13 and -2 days prepartum were 5.3 +/- .4 (n = 61), reached a peak of 14.8 +/- .3 ng/ml the day of calving, and remained high for 2 days postpartum. Estradiol increased through prepartum sampling from 23.3 to 339.6 +/- 94.1 pg/ml the day of calving, then declined abruptly. Progestins began to decline about -5 days prepartum from mean concentration of 4.09 +/- .62 (n = 25) and attained low concentrations (.30 +/- .06 ng/ml) 2 days postpartum. Although there was a surge of glucocorticoids at parturition, this was not associated with a modification in adrenal responsiveness or with prepartum concentrations of other steroid hormones of plasma. Adrenal potential in prepartum and postpartum dairy cows appears well maintained.     

Effect of exogenous corticotropin and climatic conditions on bovine adrenal cortical function.

Interactions between three climatic conditions and exogenous adrenocorticotropin (200 IU) or saline on glucocorticoids of plasma were tested in six pregnant Holstein heifers. Animals were under cold (5 C, 30% relative humidity), thermoneutral (18 C, 50% relative humidity), and hot (35 C, and 80% relative humidity) conditions. Effects of treatment, interactions of environment with treatment, and environment with treatment with interval on glucocorticoids of plasma were measured through timed intervals of blood collection at pre- and postintravenous injection of a treatment solution. Adrenocorticotropin elevated corticoid concentrations in plasma, but interactions of environment with treatment and environment by treatment by sampling interval were nil for responses of corticoids in plasma.     

Changes of luteinizing hormone and progesterone for dairy cows after gonadotropin-releasing hormone at first postpartum breeding

Gonadotropin-releasing hormone administered at breeding enhances fertility of dairy cows, so a study was designed to evaluate the mechanism for enhanced fertility following administration of gonadotropin-releasing hormone at first postpartum breeding. Twenty-four cows were assigned randomly to one of two treatments, 100 micrograms of gonadotropin-releasing hormone intramuscular or saline vehicle intramuscular at insemination. Blood samples for luteinizing hormone assay were taken at 2-h intervals prior to breeding and .5-h intervals for 3 h after insemination. Composite morning milk samples for progesterone assay were collected for 30 days after insemination or until next estrus. Cows given gonadotropin-releasing hormone had higher luteinizing hormone concentrations in blood serum following treatment than cows given saline, 13.2 versus 3.0 ng/ml. There was no relationship between luteinizing hormone and subsequent conception. Progesterone for cows that became pregnant was higher throughout sampling days. Mean progesterone concentrations were 4.6 versus 2.2 ng/ml in pregnant and nonpregnant cows during the first 4 days after insemination. Cows treated with gonadotropin-releasing hormone that conceived had higher progesterone than other cows, and that was evident at the first 4 days postbreeding.     

Luteinizing hormone and testosterone concentrations in plasma of bull calves treated with gonadotropin releasing hormone.

Twelve bull calves, 2 to 24 days of age, were assigned to two groups of six calves and administered a single 50 microng intramuscular injection of gonadotropin releasing hormone. Bull calves in group 1 were 2 to 5 days of age (mean 3.0 days), and bull calves in group 2 were 10 to 24 days of age (mean 17.1 days). Blood plasma for radioimmunoassay of luteinizing hormone and testosterone was collected at .5-h intervals for 3-h and at 4- and 6-h following treatment. With increasing age, preinjection luteinizing hormone concentrations in plasma decreased while preinjection testosterone concentrations increased. Mean preinjection luteinizing hormone concentrations for group 1 (1.01 +/- .07 ng/ml; mean +/- standard error) were higher than for group 2 (.61 +/- .12 ng/ml). Preinjection luteinizing hormone and testosterone concentrations were correlated--.63. Following treatment, luteinizing hormone increased with mean peak concentrations of 7.28 +/- .74 and 6.95 +/- 1.79 ng/ml for groups 1 and 2. Peak testosterone response following gonadotropin releasing hormone was higher for group 2 than 1 (1077 +/- 253 versus 436 +/- 116 pg/ml).     

Response of lactating dairy cows to fat supplementation during heat stress.

Effects of supplemental prilled long-chain fatty acids on lactation performance during heat stress were examined using eight multiparous Holstein cows in a replicated 4 x 4 Latin square design with 15-d periods. Cows were ruminally cannulated and were assigned randomly to one of four treatments in a 2 x 2 factorial arrangement of treatments. Factors were 0 or 5% supplemental fat and thermoneutral or heat stress conditions. Cows were housed in environmental chambers with thermoneutral conditions of 20.5 degrees C and 38% relative humidity for 24 h/d or heat stress conditions of 31.8 degrees C and 56% relative humidity for 14 h/d and 25.9 degrees C with 56% relative humidity for 10 h/d. Isonitrogenous diets (17% CP) containing 50% alfalfa silage and 50% concentrate were offered for ad libitum intake. Diets contained 1.64 or 1.83 Mcal NEL/kg DM. No diet by environment interactions were significant. Milk fat percentage (3.46 vs. 3.15%) and 3.5% FCM (31.5 vs. 29.2 kg/d) were higher for cows fed 5 vs. 0% fat. Dry matter intake, milk yield, and milk protein percentage did not differ between diets. Heat stress decreased DMI, milk yield, 3.5% FCM, and milk protein percentage but did not affect milk fat percentage. Results suggest that supplemental fat at 5% of diet DM enhances lactation performance similarly under thermoneutral and heat stress conditions.     

Transitory changes in plasma progestins, estradiol, and luteinizing hormone approaching ovulation in the bovine.

Progestins, estradiol, and luteinizing hormone were measured by radioimmunoassay in bovine plasma samples collected from indwelling jugular catheters daily on days minus 6 to minus 4, every 6 h on days minus 3 and minus 2, and every 2 h from day minus 1 to ovulation. Least squares analyses characterized time trends within animals and interrelationships between these hormones. Plasma progestins decreased from 5.7 ng/ml at day minus 6 to .07 ng at the peak of luteinizing hormone. No preovulatory peripheral increase in plasma progestins was detected. Estradiol increased from 2 pg/ml at day minus 4 to 6 pg at minus 12 h and then increased abruptly to 7.4 pg at the peak of luteinizing hormone. This matter increase in estradiol was synchronous with the acute preovulatory surge of luteinizing hormone. Association was positive between estradiol and luteinizing hormone, but negative between progestins and estradiol. Estradiol decreased 50% by 5 h following the peak of luteinizing hormone with a return to base (2 pg) at 14 h. An increase of .1 ng luteinizing hormone/ml plasma per day was linear from day minus 6 to 8 h prior to the luteinizing hormone peak. Luteinizing hormone increased to a peak of 13.5 ng/ml and remained elevated for 10.5 h. These results are consistent with the hypothesis that an increase at proestrus in estradiol rather than progestins triggers the preovulatory surge of luteinizing hormone in the bovine.     

Modulation of sex hormone secretion in cows by acute infection with bovine viral diarrhoea virus

Bovine viral diarrhoea virus (BVDV) is a major pathogen of cattle and is responsible for considerable reproductive loss. In this study, the in vivo responses in six multiparous cows were investigated after a non-cytopathogenic BVDV challenge (strain Pe 515; 5 x 10(6) tissue culture infective dose 50) given 9 days before a synchronized ovulation. Six similar cows challenged with non-infectious culture medium served as controls. The experimental noncytopathogenic BVDV infection was followed by a viraemia and leucopenia at days 5-9 after challenge, but no other clinical signs of infection were detected. However, the BVDV infection altered endocrine function. Mean LH pulse frequency immediately before CIDR withdrawal was lower (P < or = 0.05) in the BVDV-infected (2.17 +/- 0.34 pulses per 8 h) compared with the sham-infected (4.83 +/- 1.04 pulses per 8 h) animals. At day 3 after CIDR withdrawal, plasma oestradiol concentrations remained high (P < 0.05) in the infected cows (2.19 +/- 0.51 pg ml(-1)) compared with the sham-infected controls (0.72 +/- 0.29 pg ml(-1)). However, there was no difference in the peak oestradiol concentration (BVDV: 2.31 +/- 0.29 versus sham: 2.34 +/- 0.41 pg ml(-1)). In addition, non-cytopathogenic BVDV significantly (P < 0.05) increased the duration of the interval between ovulation and onset of the postovulatory progesterone increase (values 1.0 ng ml(-1)) (BVDV: 3.0 +/- 0.26 versus sham: 4.0 +/- 0.26 days). The viral infection also significantly (P < 0.01) decreased mean plasma progesterone concentrations between day 3 and day 11 after ovulation (BVDV: 2.59 +/- 0.32 versus sham: 4.13 +/- 0.27 ng ml(-1)). These data show that non-cytopathogenic BVDV viraemias during the follicular phase can modulate the secretion of gonadotrophins and sex steroids, in particular progesterone, during a synchronized oestrous cycle. Therefore, viraemias during the follicular phase may reduce the fertility of cattle by disrupting the capacity of the ovulatory follicle to form a competent corpus luteum, thereby compromising early embryo development and maternal recognition of pregnancy.     

Effects of selection for milk yield on growth hormone response to growth hormone releasing factor in growing Holstein calves

Bull and heifer calves (n = 81) from genetic lines of Holstein cows that differed by more than 4000 kg milk/305-d lactation were used to determine effects of selection for milk yield on growth hormone (GH) response to a GH releasing factor (GRF) analog. Calves received GRF (4 microg/100 kg BW) on 10, 56, 140, 196, 252, and 364 +/- 3 d of age. Jugular blood samples (n = 15) were obtained from -30 to 120 min relative to GRF administration. Area under the GH response curve (0 to 60 min, AUC60) was quantified after subtracting mean prechallenge GH concentrations. Data were analyzed for effects of line, age, gender, and their interactions with PROC MIXED of SAS for repeated measures and incorporated the spatial power law for unequally spaced data with age as the repeated effect. Means were considered different when P < 0.05. Prechallenge GH concentrations did not differ between lines, were greater in bulls than heifers (4.6 vs. 3.7 ng/ml), and decreased with age. The AUC60 decreased with age but did not differ between lines. Heifers responded more to GRF than bulls (1550 vs. 1336 ng x min/ml). Peak GH concentration decreased with age and was less in bulls than heifers (54.7 vs. 62.1 ng/ml) but did not differ between lines. Although plasma GH has been identified as an inheritable trait, we conclude the GH variables measured in this study were not useful in predicting genetic merit of calves from these substantially different lines of cows.     

Effect of adrenocorticotropic hormone and associated hormonal responses on semen quality and sperm output of bulls

The objective was to determine if semen quality and output could be affected by pharmacological doses of adrenocorticotropin. Three Holstein bulls, one 7 yr old and two yearlings, were treated with 200 IU adrenocorticotropic hormone every 8 h for 6 days. Effects of treatment on semen traits and peripheral concentrations of glucocorticoids, testosterone, and androstenedione were measured. Viability of spermatozoa (percentage motility and percentage intact acrosomes), ejaculate volume, sperm concentration, and weekly sperm output were unaffected by adrenocorticotropin treatment up to 8 wk posttreatment. The proportion of spermatozoa with cytoplasmic droplets and head abnormalities was elevated slightly from .8 +/- .1 and 4.2 +/- .3% to 1.3 +/- .2 and 5.8 +/- .4% during treatment. Total glucocorticoids increased from 11.9 +/- 2.7 ng/ml before treatment to 73.5 +/- 4.1 ng/ml during treatment. Testosterone decreased in the yearling bulls from 5.5 +/- .9 ng/ml plasma before treatment to .5 +/- .5 ng/ml afterward; the decrease began 8 h following the initial adrenocorticotropin injection and persisted until 24 h following last injection. The mature bull had normal testosterone concentrations for the first 4 days of injection, and decreased concentrations for the last 2 days of injection. Semen viability, concentration, and sperm output are unaffected by a pharmocological administration of adrenocorticotropin and subsequent marked increase of glucocorticoids and decrease of testosterone. Only a small increase of semen content of immature sperm or sperm with abnormal heads may be associated with these marked endocrine changes.     

Early postpartum reproductive profiles in Holstein cows with retained placenta and uterine discharges

Sixty Holstein cows were allocated to three groups. Twenty cows had retained placenta. The remaining cows were examined on d 14 postpartum and those with purulent discharges (n = 22) were assigned to one group and the remaining (n = 18) to a control group. Within each group, cows were given randomly either gonadotropin-releasing hormone (i.m., 200 micrograms) or saline on d 15 postpartum to evaluate the effect on changes in ovarian structures and plasma progesterone through 50 d postpartum and fertility. Corpora lutea were found in control cows by d 21, cows with uterine discharge by d 28, and cows with retained placenta by d 27. Maximum progesterone production during the first luteal phase was higher in control cows than in cows with purulent discharge or retained placenta (4.66 ng/ml compared with 3.23 and 3.34 ng/ml, respectively). Duration of the first corpus luteum was affected by clinical condition. Only 6.2% of cows with retained placenta had corpora lutea of normal duration (12 to 16 d), whereas 43.8 and 50.0% of cows with uterine discharge and control cows had normal postpartum luteal phases. Measures of fertility were not affected by gonadotropin-releasing hormone. Control cows had less days to conception (97) and fewer services per conception (1.6) than cows with retained placenta (134 and 2.5, respectively). Clinical group affected reproduction more than gonadotropin-releasing hormone did, possibly by altering ovarian function.     

Continuous elevation of blood growth hormone concentrations by beeswax implant

We examined constancy of release of purified ovine growth hormone from an implant containing soybean oil and beeswax. Implants contained an amount of growth hormone that was sufficient to increase concentrations in blood plasma by 20 and 40 ng/ml and to maintain those concentrations over 1 wk. Growth hormone in plasma increased to approximately 65 ng/ml in lambs receiving low dose implants the 1st day after implantation, returned to 31 ng/ml on day 2, and remained near this concentration for the remainder of the week. Pulse release of growth hormone was not similiar in the high dose lambs where growth hormone concentration in plasma averaged 45 ng/ml 1 day after implantation, then gradually increased to 60 ng/ml on day 6. Unimplanted control lambs had mean growth hormone concentrations of 2.9 to 3.9 ng/ml throughout the 6-day observation. This approach should interest investigators studying the chronic influence of purified or synthetic growth hormone on dairy cows, beef steers, or lambs.     

Testosterone concentrations in plasma of dairy cows with ovarian cysts.

Testosterone in plasma was measured by radioimmunoassay in cows with ovarian cysts and in cows during the estrous cycle. Concentrations of testosterone in plasma (60.8 +/- 2.7 pg/ml; mean +/- standard error) in cows with ovarian cysts were variable but within the range in cows during the estrous cycle. Mean concentrations of testosterone in plasma increased from 46.3 pg/ml at estrus to 85.1 pg/ml on day 13 of the estrous cycle. In cows with ovarian cysts, concentrations of testosterone in plasma declined within 24 h following prostaglandin F2 alpha and tended to increase by 9 days following gonadotropin releasing hormone. The role of testosterone in estrual behavior and inhibiting resumption of ovarian cycles is likely minimal.     

Plasma adrenocorticoid response to corticotropin in dairy cattle fed high silage diets.

Responses of plasma corticoids to adrenocorticotropic hormone (.32 U/kg body weight) administered during early lactation were measured in dairy cattle consuming large amounts of concentrate feeds and one of the following forage diets: alfalfa-timothy hay plus corn silage, alfalfa-timothy hay crop silage plus corn silage, or corn silage. Concentrations of plasma corticoids increased to maximum in all groups within 60 to 90 min. Concentrations remained at near maximum for 4 to 5 h and then declined to baseline. Maximum corticoid concentrations following adrenocorticotropic hormone injection differed among forage treatment groups. Responses of corn silage and hay crop silage groups (46.7 +/- 1.1 and 50.1 +/- 2.4 ng/ml) did not differ but were less than those in the hay group (65.5 +/- 2.9 ng/ml). Response measured as area under the curve of plasma corticoid response also differed among forage treatments: hay 443 +/- 17 h (ng/ml) is greater than hay crop silage 334 +/- 34 is greater than corn silage 245 +/- 36. Results are discussed in terms of stress susceptibility in dairy cattle consuming diets containing large amounts of silage.     

Dynamics of gonadotropin release following ovariectomy and injection of gonadotropin-releasing hormone in early postpartum dairy cows

The influence of the ovary and of injection of low doses of gonadotropin-releasing hormone on secretion and gonadotropin-releasing hormone-induced release of gonadotropins in early postpartum cows was examined in a 2 x 2 factorial design (6 cows/group). Twelve cows were ovariectomized 2 d postpartum (calving = d 0; groups 1 and 2) and 12 cows were left intact (groups 3 and 4). Groups 1 and 3 received gonadotropin-releasing hormone (5 micrograms) every 120 min for 70 h from d 6 to d 9; groups 2 and 4 received saline by the same regimen. All animals received 50 micrograms gonadotropin-releasing hormone on d 9. Mean concentrations of FSH were higher following ovariectomy compared with those of intact cows 6 to 8 d postpartum, whereas no differences in FSH were observed between cows receiving gonadotropin-releasing hormone or saline during this period. Concentrations of LH were similar in intact and ovariectomized cows on d 6 to 8 but were increased in cows receiving gonadotropin-releasing hormone compared with cows receiving saline. Ovariectomy did not alter the gonadotropin-releasing hormone-induced release of gonadotropins on d 9. Injection of gonadotropin-releasing hormone on d 6 to 8 resulted in a decreased gonadotropin-releasing hormone-induced release of gonadotropins on d 9. It was concluded that removal of ovarian influence resulted in increased secretion of FSH but did not affect gonadotropin-releasing hormone-induced release of LH and FSH during the early postpartum period.     

Effects of somatotropin on milk yield and physiological responses during summer farm and hot laboratory conditions

The effects of bST on performance and physiological responses of lactating cows was studied under farm summer and laboratory heat conditions. Twelve cows, 90 to 50 d postpartum, were injected with either bST or vehicle solution for 30 d under farm summer and 10 d under either laboratory thermoneutral or heat conditions. Somatotropin increased milk yield by 6.1 (21%), 8.1 (32%), and 7.3 kg (35%) under the farm summer, laboratory thermoneutral, and heat conditions, respectively. Somatotropin also increased milk fat by 15 and 19% and dry matter intake by 16 and 18% under laboratory thermoneutral and heat conditions, respectively. Somatotropin increased the efficiency of feed conversion into milk without any significant changes in body weight and temperatures. Somatotropin reduced plasma concentrations of triiodothyronine and cortisol and had no effect on plasma prolactin and insulin concentrations. Somatotropin did not increase water intake; however, hematocrit was decreased. The results suggest that stimulatory effects of bST on milk production are still observed on heat-stressed cows without any significant indications of additional heat stress.     

First postpartum luteal function in dairy cows after ovulation induced by progestogen and gonadotropin-releasing hormone

The objective was to determine the effects of progestogen treatment on the lifespan of the first corpus luteum induced by GnRH in periparturient-milked cows. Dairy cows (n = 55) were assigned randomly following normal parturitions to receive either a progestogen implant (6 mg of norgestomet) or a blank implant (control) for 6 d beginning 2 to 5 d after calving. Fifty micrograms of GnRH were administered i.m. 72 h after implant removal to induce ovulation. Concentrations of LH and FSH in serum from 24 to 30 h and from 66 to 72 h after implant removal were similar among treatments. The magnitude of LH released after GnRH injection was higher in progestogen-treated cows (7.6 +/- .9 ng/ml) than in controls (5.3 +/- .9 ng/ml). Concentrations of estradiol in serum from the beginning of the implant period until 3 d after GnRH injection were higher in cows receiving progestogen (9.1 +/- 1.7 pg/ml) than in controls (5.6 +/- 1.7 pg/ml). The proportion of cows that responded to GnRH (elevated concentrations of progesterone in serum greater than .5 ng/ml within 3 to 5 d after injection) tended to be higher in cows receiving progestogen (24 of 28) than in control cows (19 of 27). By definition, interval to first ovulation after GnRH injection was shorter in cows responding to GnRH (3.8 +/- .5 d) than in those failing to respond (20.2 +/- .9 d).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of pattern of administration of bovine growth hormone on lactational performance of dairy cows

Bovine growth hormone was administered to Holstein cows (late lactation) in a 4 X 4 Latin square design. Treatments were 1) control, subcutaneous injection of placebo, 2) subcutaneous injection of 25 IU growth hormone every 2nd d, 3) daily subcutaneous injection of 25 IU growth hormone, 4) continuous subcutaneous infusion of 25 IU/d growth hormone. Daily profiles of growth hormone in plasma consisted of: 1) a relatively constant concentration averaging 4.5 ng/ml for control, 2) a single peak of 21 to 25 ng/ml followed by a steady decline to baseline for treatments involving daily or alternate day injection (in the latter case concentrations maintained at baseline during the 2nd d after injection), and 3) a relatively constant elevation to 10.6 ng/ml for the continuous subcutaneous infusion. Total growth hormone in plasma increased in proportion to average daily dose of exogenous growth hormone. Milk yield responses in the daily injected and infused groups did not differ and averaged 28% over controls. Gross efficiency (milk energy/consumed energy) was increased 16% by daily administration of 25 IU growth hormone. Responses to the alternate day injection were approximately half those predicted for an average dose of 12.5 IU/d. No particular pattern in plasma growth hormone concentration need be attained to achieve lactational response to exogenous growth hormone. However, extending the interval between injections beyond 24 h may diminish the response per unit of growth hormone injected.     

Gonadotropin-releasing hormone and conception of Holsteins

Effects of gonadotropin-releasing hormone (100 micrograms) and time of artificial insemination on fertility, were examined in lactating dairy cows at first, second, and third services. Inseminations were either soon after detected estrus (0 h) or 12 h later, and cows were given gonadotropin-releasing hormone or saline after inseminations. Conception at first service was not improved by hormone treatment. But conception rates at repeat services were improved by nearly 21% when cows were treated with gonadotropin-releasing hormone within 30 s after insemination. Inseminations soon after detection of estrus (0 h) followed by hormone treatment resulted in the highest conception rates for all services. Time of the insemination (0 versus 12 h) had no effect on conception. Administering gonadotropin-releasing hormone at repeat services should improve conception rate of lactating dairy cows.     

Alpha-lactalbumin in bovine serum: relationships with udder development and function

Concentrations of alpha-lactalbumin in blood from cattle in various physiological states were measured as an index of udder development and function. Included were primiparous heifers during gestation and the peripartum period, nonlactating, nonpregnant cows hormonally induced into lactation, and cows milked two or three times daily in early, middle, or late lactation. Concentrations of alpha-lactalbumin in serum increased in two phases during gestation. Initial values (7.3 ng/ml, up to 120 d prepartum) rose, then leveled at 29.9 ng/ml on d 120 to 30 prepartum. Concentrations subsequently increased, averaging 133.2 ng/ml over the 30 d prior to parturition. During the peripartum period, alpha-lactalbumin rose from 221.2 ng/ml on d 4 prepartum, peaked at calving (918.8 ng/ml), then declined, stabilizing at approximately 500 ng/ml (1.5 to 3 d postpartum). Concentrations of alpha-lactalbumin in cows induced to lactate were low on d 1 to 9 of hormone treatment (15.7 ng/ml), rose to a maximum on d 17 (803.4 ng/ml), then fell to a plateau (185.8 ng/ml) on d 21 to 25. alpha-Lactalbumin concentrations were higher in early (101.9 ng/ml) than in middle or late lactation (81.4 and 79.2 ng/ml, respectively). Concentrations were also greater in twice versus thrice milked cows (101.9 vs. 73.0 ng/ml). Changes in alpha-lactalbumin concentrations in serum are associated with developmental and functional status of the udder. The measurement provides a noninvasive method to assess mammary gland activity.